Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- ANTCliPh Completes PK Study in Patients with Renal Disorders
April 2, 2007
- 1st Gov't-Industry Dialogue Held on Distribution Issues
April 2, 2007
- Clinical Research on Regenerative Medicine for Spinal Injuries to Start
April 2, 2007
- R&D NEWS IN BRIEF
April 2, 2007
- Switch OTC Version of Aciclovir Recommended for Approval
April 2, 2007
- SELF-MEDICATION NEWS IN BRIEF
April 2, 2007
- OPINION：Just What the Doctor Ordered
April 2, 2007
- SymBio Licenses AB-1001 from Abeille
March 26, 2007
- Multiple Drug-Resistant P. Aeruginosa Detected in 85.8% of Core Hospitals
March 26, 2007
- Wholesalers Should Ally with Dispensing Pharmacies: Mr Kimura
March 26, 2007
- Number of Local Gov't Hospitals Drops below 1,000: MIC White Paper
March 26, 2007
- BUSINESS NEWS IN BRIEF
March 26, 2007
- Generics to Be Listed for 6 Major Products with Sales of Over \10 Bil.
March 26, 2007
- 152 Generics Approved for the Same Indications as Original Drugs
March 26, 2007
- Generics Should Use the Same Excipients as Original Drugs: Dr Kawashima of Santen
March 26, 2007
- NEW PRODUCT
March 26, 2007
- Kyorin to License at Least 1 Compound Per Year at Late Stage
March 26, 2007
- Korosho Proposes 7 Measures to Promote Innovation
March 26, 2007
- Japan-China Medical Cooperation Initiatives to Symbolize Fraternity: Mr Niwa
March 26, 2007
- R&D NEWS IN BRIEF
March 26, 2007
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…